GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Pharmarise Holdings Corp (TSE:2796) » Definitions » EV-to-FCF

Pharmarise Holdings (TSE:2796) EV-to-FCF : (As of May. 25, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Pharmarise Holdings EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Pharmarise Holdings's Enterprise Value is 円12,752 Mil. Pharmarise Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Feb. 2024 was 円0 Mil. Therefore, Pharmarise Holdings's EV-to-FCF for today is .

The historical rank and industry rank for Pharmarise Holdings's EV-to-FCF or its related term are showing as below:

TSE:2796' s EV-to-FCF Range Over the Past 10 Years
Min: -18.83   Med: -16.49   Max: 42.54
Current: 6.45

During the past 13 years, the highest EV-to-FCF of Pharmarise Holdings was 42.54. The lowest was -18.83. And the median was -16.49.

TSE:2796's EV-to-FCF is ranked better than
87.53% of 361 companies
in the Healthcare Providers & Services industry
Industry Median: 19.29 vs TSE:2796: 6.45

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-25), Pharmarise Holdings's stock price is 円654.00. Pharmarise Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2024 was 円24.848. Therefore, Pharmarise Holdings's PE Ratio for today is 26.32.


Pharmarise Holdings EV-to-FCF Historical Data

The historical data trend for Pharmarise Holdings's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmarise Holdings EV-to-FCF Chart

Pharmarise Holdings Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26.61 11.62 9.63 51.91 5.19

Pharmarise Holdings Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 5.19 - - -

Competitive Comparison of Pharmarise Holdings's EV-to-FCF

For the Pharmaceutical Retailers subindustry, Pharmarise Holdings's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pharmarise Holdings's EV-to-FCF Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Pharmarise Holdings's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Pharmarise Holdings's EV-to-FCF falls into.



Pharmarise Holdings EV-to-FCF Calculation

Pharmarise Holdings's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=12752.063/0
=

Pharmarise Holdings's current Enterprise Value is 円12,752 Mil.
Pharmarise Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Pharmarise Holdings  (TSE:2796) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Pharmarise Holdings's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=654.00/24.848
=26.32

Pharmarise Holdings's share price for today is 円654.00.
Pharmarise Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円24.848.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Pharmarise Holdings EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Pharmarise Holdings's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmarise Holdings (TSE:2796) Business Description

Traded in Other Exchanges
N/A
Address
8 Floor, Sumitomo Nakano Sakue Building, 1-38-1 Chuo, Nakano-ku, Tokyo, JPN, 164-0011
Pharmarise Holdings Corp is engaged in the operation of dispensing pharmacies, which prescribe medicines to general patients based on prescriptions issued by medical institutions. It is also engaged in the storage and management of medical examination records of patients on behalf of the medical institution.

Pharmarise Holdings (TSE:2796) Headlines

No Headlines